Results 81 to 90 of about 23,339 (211)

Subacute Thyroiditis Without Neck Pain: An Unusual Cause of Persistent Fever in the Elderly Patient

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Subacute thyroiditis can present as fever of unknown origin, particularly in elderly patients. Absence of neck pain or thyroid tenderness does not exclude the diagnosis. Thyroid function tests and inflammatory markers are key to diagnosis. Corticosteroids lead to rapid symptomatic improvement in moderate‐to‐severe cases.
Abdullah Shahid   +9 more
wiley   +1 more source

Aortitis in Extracranial Giant Cell Arteritis: Do Not Lose Sight of the Patient

open access: yesAnnals of Internal Medicine: Clinical Cases
Giant cell arteritis is the most common systemic vasculitis. This case highlights aortic dissection as a potentially life-threatening complication of giant cell arteritis, in most instances occurring as very late event years or even decades after initial
Lilly J.U. Reik   +3 more
doaj   +1 more source

Diffuse large B cell lymphoma involving Meckel’s cave masquerading as biopsy-negative giant cell arteritis: a case report

open access: yesJournal of Medical Case Reports, 2020
Background Given the absence of consensus diagnostic criteria for giant cell arteritis, clinicians may encounter difficulty with identification of new-onset headache in patients older than age 50 years presenting with visual changes and elevated ...
Matthew J. Samec   +3 more
doaj   +1 more source

Varicella Zoster Virus Infection: Clinical Features, Molecular Pathogenesis, Treatment, and Prevention

open access: yesMedComm, Volume 7, Issue 3, March 2026.
This review focuses on the clinical features, molecular mechanisms, treatment methods, and preventive measures of the VZV, with the aim of providing a theoretical basis for the development of new treatment and prevention methods for HZ. ABSTRACT Varicella zoster virus (VZV) is a ubiquitous human herpesvirus that establishes lifelong latency and causes ...
Lei Peng   +8 more
wiley   +1 more source

Comorbidity in polymyalgia rheumatica [PDF]

open access: yes, 2018
Polymyalgia rheumatica (PMR) is the commonest inflammatory rheumatic disease affecting older people. The current mainstay of treatment is long-term oral glucocorticoid therapy. Management of these patients in clinical practice is often complicated by the
Chatzigeorgiou, C, Mackie, SL
core   +2 more sources

Bridging FDA Adverse Event Reporting System (FAERS) and Clinical Practice: Comprehensive Characterization of Immune Checkpoint Inhibitors Toxicities in Geriatric Lung Cancer Patients

open access: yesThoracic Cancer, Volume 17, Issue 6, March 2026.
Elderly lung cancer patients face increased risks of severe and fatal AEs during ICIs treatment. Reports concerning males, Asians, and anti‐PD‐1 recipients were associated with higher odds of a fatal outcome. Immune‐mediated pneumonitis is the most frequently reported severe AE, calling for heightened vigilance for these high‐risk subgroups.
Yumeng Tian   +5 more
wiley   +1 more source

The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease [PDF]

open access: yes, 2018
Purpose: This study was performed to investigate the value of 18F-fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.
Melzer, Ralph   +5 more
core  

Isolated Aortitis: a Rare Cause of Febrile Illness [PDF]

open access: yes, 2015
Febrile illness often presents a challenge for the clinician. The main causes of febrile illness are infections, solid or haematological malignancies and connective tissue disorders, including vasculitis.
Barreto, P, Fior, A
core   +1 more source

Basophil Activation Test for the In Vitro Diagnosis of Tocilizumab Hypersensitivity

open access: yes
Clinical &Experimental Allergy, EarlyView.
Ana Koren   +3 more
wiley   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

open access: yesJournal of the American Geriatrics Society, Volume 74, Issue 3, Page 636-647, March 2026.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy